Clinical Trial

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Name: Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes — clinical trial record (NCT07317115)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MAGvMED

Recruiting

View on ClinicalTrials.gov →

Summary

Compare use of the Magnet System in side-to-side duodeno-ileostomy (Surgery) with semaglutide (Medication).

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-12-19; most recent amendment 2026-05-18.

Trial Details

NCT Number	NCT07317115
Lead Sponsor	GT Metabolic Solutions, Inc.
Conditions	Obesity (Disorder), Obesity & Overweight, Type 2 Diabetes (T2DM)
Enrollment	20 participants
Start Date	2026-03-18
Primary Completion	2027-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-19